EEF1E1 promotes glioma proliferation by regulating cell cycle through PTEN/AKT signaling pathway
暂无分享,去创建一个
Ruiqin Han | Junqiang Dai | Q. Dong | W. Kang | Qiao Li | Hang Yin | G. Yuan | Yawen Pan | Hongyu Wang | Liang Niu | Yunji Yan | He Zhang | Xuanxuan Yao | Yuanping Su
[1] Bingying Zhou,et al. Dysregulation of interaction between LOXhigh fibroblast and smooth muscle cells contributes to the pathogenesis of aortic dissection , 2022, Theranostics.
[2] Ruiqin Han,et al. A Novel HCC Prognosis Predictor EEF1E1 Is Related to Immune Infiltration and May Be Involved in EEF1E1/ATM/p53 Signaling , 2021, Frontiers in Oncology.
[3] Sunghoon Kim,et al. Structural basis for the dynamics of human methionyl-tRNA synthetase in multi-tRNA synthetase complexes , 2021, Nucleic acids research.
[4] P. Sicinski,et al. Targeting cell-cycle machinery in cancer. , 2021, Cancer cell.
[5] Yan Liu,et al. Exosomal miR-10b-5p mediates cell communication of gastric cancer cells and fibroblasts and facilitates cell proliferation , 2021, Journal of Cancer.
[6] Hongbo Xin,et al. AIMP3 inhibits cell growth and metastasis of lung adenocarcinoma through activating a miR‐96‐5p‐AIMP3‐p53 axis , 2021, Journal of cellular and molecular medicine.
[7] Q. Qi,et al. Acetyl-11-keto-β-boswellic acid inhibits proliferation and induces apoptosis of gastric cancer cells through the phosphatase and tensin homolog /Akt/ cyclooxygenase-2 signaling pathway , 2020, World journal of gastroenterology.
[8] J. Barnholtz-Sloan,et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. , 2020, Neuro-oncology.
[9] L. Cao,et al. Hormone-Like Effects of 4-Vinylcyclohexene Diepoxide on Follicular Development , 2020, Frontiers in Cell and Developmental Biology.
[10] Xizhe Li,et al. Immunotherapy for glioma: current management and future application. , 2020, Cancer letters.
[11] Jennie W. Taylor,et al. Genetic and molecular epidemiology of adult diffuse glioma , 2019, Nature Reviews Neurology.
[12] Hongtae Kim,et al. AIMP3 Deletion Induces Acute Radiation Syndrome-like Phenotype in Mice , 2018, Scientific Reports.
[13] Jill S Barnholtz-Sloan,et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. , 2018, Neuro-oncology.
[14] Sunghoon Kim,et al. AIMP3 depletion causes genome instability and loss of stemness in mouse embryonic stem cells , 2018, Cell Death & Disease.
[15] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[16] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[17] Abhi Veerakumarasivam,et al. Loss of expression of the tumour suppressor gene AIMP3 predicts survival following radiotherapy in muscle‐invasive bladder cancer , 2014, International journal of cancer.
[18] Sunghoon Kim,et al. AIMP3/p18 controls translational initiation by mediating the delivery of charged initiator tRNA to initiation complex. , 2012, Journal of molecular biology.
[19] Bensheng Qiu,et al. Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas , 2012, Journal of magnetic resonance imaging : JMRI.
[20] P. Pandolfi,et al. The functions and regulation of the PTEN tumour suppressor , 2012, Nature Reviews Molecular Cell Biology.
[21] S. Leenstra,et al. Recent advances in the molecular understanding of glioblastoma , 2012, Journal of Neuro-Oncology.
[22] M. Barbacid,et al. Cell cycle, CDKs and cancer: a changing paradigm , 2009, Nature Reviews Cancer.
[23] Lewis C. Cantley,et al. AKT/PKB Signaling: Navigating Downstream , 2007, Cell.
[24] Seung Yong Park,et al. AIMP3 haploinsufficiency disrupts oncogene-induced p53 activation and genomic stability. , 2006, Cancer research.
[25] P. Kleihues,et al. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. , 2005, Journal of neuropathology and experimental neurology.
[26] B. Clurman,et al. Cyclin E in normal and neoplastic cell cycles , 2005, Oncogene.
[27] Sunghoon Kim,et al. The Haploinsufficient Tumor Suppressor p18 Upregulates p53 via Interactions with ATM/ATR , 2005, Cell.
[28] James M. Roberts,et al. Living with or without cyclins and cyclin-dependent kinases. , 2004, Genes & development.
[29] Shunyou Wang,et al. PTENless means more. , 2004, Developmental biology.
[30] V. Ambros,et al. An Extensive Class of Small RNAs in Caenorhabditis elegans , 2001, Science.
[31] Francisca Vazquez,et al. Phosphorylation of the PTEN Tail Regulates Protein Stability and Function , 2000, Molecular and Cellular Biology.
[32] Hong Sun,et al. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. , 1997, Cancer research.
[33] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[34] C. Downes,et al. Stimulation of PI 3-kinase signaling via inhibition of the tumor suppressor phosphatase, PTEN. , 2007, Advances in enzyme regulation.